Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.

ABSTRACT:

Background

Little is known about health-related quality of life (HRQOL) following treatment for bladder cancer (BC).

Objective

To determine this, we undertook a cross-sectional survey covering 10% of the English population.

Design, setting, and participants

Participants 1-10 yr from diagnosis were identified through national cancer registration data.

Intervention

A postal survey was administered containing generic HRQOL and BC-specific outcome measures. Findings were compared with those of the general population and other pelvic cancer patients.

Outcome measurements and statistical analysis

Generic HRQOL was measured using five-level EQ-5D (EQ-5D-5L) and European Organization for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ)-

SUBMITTER: Catto JWF 

PROVIDER: S-EPMC8082273 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature